Global Ganja Report

Political space for cannabis is generally on the upswing, but there are some intersecting trends that advocates will need to keep a sharp eye on in the coming year. Corporate cannabis will increase pressure on independent producers, while prohibitionists will try to leverage the vape health scare for anti-cannabis propaganda. And the cannabis industry's own terminology may be actually adding to the confusion.

Voters in New Jersey will decide whether to legalize cannabis in the Garden State next year. A measure approved by both houses of the state Legislature officially places the question on the 2020 ballot—ending long months of inaction on a promised legalization bill.

So-called "smokable hemp" is suddenly available in shops from coast to coast, legal under terms of last year's Farm Bill. But law enforcement is consternated, conservative politicians are apoplectic, and legislation is being prepared to ban the stuff at the state level. Is this permissible under federal law?

The prosecutor for Miami-Dade County is the latest of several around the country to halt minor cannabis cases. The move was prompted by a dilemma vexing law enforcement nationwide: the inability to distinguish between THC and legal CBD in confiscated samples.

Finally settling a question that has vexed the Arizona medical marijuana program since it was launched nearly a decade ago, the state's highest court ruled that the program does indeed cover concentrates and extracts. The decision is a victory for patients who use edibles, tinctures or hashish.

The conventional wisdom—and certainly the impression made by much media and advertising—is that CBD is legal pursuant to the federal Farm Bill enacted late last year. As is often the case, however, there are some devils in the details.

In Arizona, the statehouse and supreme court are in a race to clarify whether hashish is to be included in the Grand Canyon State's medical marijuana program. The question also has implications for the status of extracts and edibles.

California health authorities dealt a blow to the burgeoning CBD business by banning preparations of the cannabinoid derived from industrial hemp rather than psychoactive cannabis. The diktat adds to the legal confusion around CBD, and highlights the need for greater clarity from the competent authorities at both the state and federal level.